Full Press Release Details
argenx Reports Third Quarter 2021 Financial Results and Provides Business Update.
ARGX
argenx Reports Third Quarter 2021 Financial Results and Provides Business Update
Key Takeaway: argenx Reports Third Quarter 2021 Financial Results and Provides Business Update
Price reaction · baseline $281.85 (2021-10-26 close) · hit after-hours · clean, no other ARGX news in the window
day 0 close · peak
-0.8%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis